Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annua
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data at the virtual 28th Annual C...
United States Leone Patterson Wendy Ryan Laura Lombardi European Society Of Gene Gene Transfer Prevents Development Of Arrhythmogenic Cardiomyopathy
Source: pharmiweb.com